SGPL1 and amyloidosis: Based on the clinical characteristics of the patient and a literature review, we speculate that this patient had multisystem amyloidosis due to the increased production of monoclonal IgA-κ protein by plasma cells as a result of a mutation in the SGPL1 gene.